I now have comprehensive information from multiple authoritative textbooks. Here is a complete clinical overview:
Inflammation of the Left Kidney (Nephritis / Pyelonephritis)
Inflammation of a kidney - regardless of which side - falls under the broad term nephritis. The most clinically common form is pyelonephritis (infection-driven inflammation), though several other types exist.
1. Terminology and Classification
| Term | Meaning |
|---|
| Nephritis | General term for kidney inflammation |
| Pyelonephritis | Infection-induced inflammation of the renal parenchyma and pelvis |
| Glomerulonephritis (GN) | Immune-mediated inflammation primarily targeting the glomeruli |
| Tubulointerstitial Nephritis (TIN) | Inflammation of tubules and interstitium (drug-induced, immune, metabolic) |
The left kidney specifically has no unique pathophysiology compared to the right, though the right kidney is slightly more commonly affected in ascending UTIs due to anatomical proximity to the ileocecal region. Unilateral pyelonephritis is common.
2. Acute Pyelonephritis - Most Common Cause
Pathogenesis
Inflammation spreads via two routes:
- Ascending route (most common): bacteria ascend from the bladder through the ureter to the renal pelvis and parenchyma
- Hematogenous route: bacteria seed the kidney through the bloodstream (e.g., in septicemia)
Obstructive lesions of the urinary tract are important predisposing factors.
"Acute bacterial nephritis occurs as the inflammation from bacterial infection within the kidney begins to spread throughout the kidney in an increasingly suppurative process with heavier leukocytic infiltrate and focal areas of tissue necrosis."
- Campbell-Walsh-Wein Urology
Causative Organisms
- E. coli is the most common pathogen
- Other gram-negatives: Klebsiella, Proteus, Pseudomonas, Enterobacter
- Bacteria induce a neutrophilic inflammatory response
- Fungi or mycobacteria cause granulomatous interstitial inflammation
Symptoms and Signs
- Fever (often high-grade, with chills/rigors)
- Flank or costovertebral angle (CVA) pain - on the left side in this patient
- Nausea and vomiting
- Lower urinary tract symptoms: dysuria, frequency, urgency
- Signs of sepsis may be present in severe cases
3. Diagnosis
Laboratory Tests
- Urine analysis: pyuria (WBCs), bacteriuria, WBC casts (pathognomonic), nitrites positive
- Urine culture: significant growth at ≥100,000 colonies/mL (though pyelonephritis can occur at counts as low as 20,000-50,000 colonies/mL)
- Blood cultures: obtained in moderate-to-severe cases
- CBC: leukocytosis with left shift
- CRP/ESR: elevated
Imaging
- Ultrasound: first-line, detects hydronephrosis, abscess, obstruction; can detect abscesses as small as 1 cm
- CT scan (contrast-enhanced): most sensitive and specific; shows wedge-shaped, poorly enhancing areas; detects perirenal fat changes and thickening of Gerota's fascia; gold standard for complications
- MRI: preferred in pregnancy to avoid radiation
A 2024 systematic review and meta-analysis (PMID:
38339768) specifically evaluated ultrasound performance in acute pyelonephritis.
4. Complications
| Complication | Description |
|---|
| Pyonephrosis | Purulent exudate accumulates in a dilated collecting system (usually with obstruction) |
| Renal abscess | Coalescence of inflammatory areas; urine culture may be negative in up to 20% of cases |
| Septicemia / Septic shock | Systemic spread of infection |
| Chronic pyelonephritis | Recurrent or persistent infection leads to irregular kidney scarring, most prominent at upper and lower poles |
| Acute kidney injury (AKI) | Occurs in up to 25% of cases in pregnant patients |
5. Treatment
Decision: Oral vs. Intravenous
The first clinical decision is whether the patient can be managed outpatient (oral) or requires hospitalization (parenteral).
Hospitalization is indicated for:
- Sepsis or hemodynamic instability
- Inability to tolerate oral medications (nausea/vomiting)
- Complicated UTI or obstruction
- Immunocompromised host
- Pregnancy (usually admitted)
Antibiotic Regimens (per Goldman-Cecil Medicine)
Empiric IV therapy:
- Aminoglycoside (e.g., gentamicin) - associated with better outcomes; preferred in areas with high resistance rates
- Transition to oral therapy at 24-48 hours if clinically improved
Oral step-down (adequate tissue penetration required):
- Trimethoprim-sulfamethoxazole
- Ciprofloxacin or levofloxacin (5-7 days sufficient)
- Cefixime
Total treatment duration: 7-14 days (5-7 days adequate for fluoroquinolones)
Agents NOT appropriate for pyelonephritis (inadequate tissue levels):
- Nitrofurantoin
- Fosfomycin
Complicated / Resistant Cases
- Meropenem 1 g every 8 hours
- Piperacillin-tazobactam 4.5 g every 8 hours
- Plazomicin (15 mg/kg once daily) - useful for highly resistant organisms
6. Other Causes of Kidney Inflammation (Differential)
If this patient's inflammation is non-infectious, consider:
- Glomerulonephritis: immune-mediated (IgA nephropathy, lupus nephritis, post-infectious GN)
- Tubulointerstitial Nephritis (TIN): caused by drugs (NSAIDs, antibiotics, PPIs), metabolic disorders (hyperuricemia, hypercalcemia), or autoimmune conditions (Sjogren syndrome, sarcoidosis)
- Xanthogranulomatous Pyelonephritis (XGP): a rare, severe, chronic inflammatory process that destroys renal parenchyma (a 2024 pooled analysis - PMID: 39254583)
7. Special Considerations
Chronic Pyelonephritis develops when anatomic anomalies cause urine reflux or outflow obstruction, leading to multiple injury episodes and irregular kidney scarring - typically more prominent at the upper and lower poles where reflux is most common. This can eventually progress to chronic kidney disease (CKD).
Sources:
- Robbins, Cotran & Kumar Pathologic Basis of Disease (Key Concepts: Pyelonephritis)
- Goldman-Cecil Medicine (Pyelonephritis Treatment, Table 263-7)
- Campbell-Walsh-Wein Urology (Bacterial Nephritis)
- National Kidney Foundation Primer on Kidney Diseases, 8e
- Comprehensive Clinical Nephrology, 7th Edition
- Textbook of Family Medicine, 9e
Clinical note: This is educational/reference information. Individual patient management requires clinical evaluation, culture sensitivity results, and physician judgment.